Company Name: Nightstar Therapeutics plc

Nightstar Therapeutics plc is a clinical stage gene therapy company. The company develops gene therapies for rare inherited retinal diseases including choroideremia and X-linked retinitis pigmentosa.

Ticker Symbol: NITE (NASDAQ)

Company Website: https://www.nightstartx.com

Headquarters: London, UK; Lexington, MA (U.S. office)